Aptitude Medical Systems
Aptitude Medical Systems is a deep-tech healthcare company dedicated to democratizing diagnostics by creating simple, accurate, and easy-to-use molecular diagnostic platforms. Their mission is to make healthcare more accessible and affordable, enabling individuals to access their health information anytime, anywhere. Their flagship product, Metrix®, is an FDA-authorized molecular diagnostic platform that offers lab-quality results in minutes, suitable for use in various settings including urgent care centers, physician offices, hospitals, and homes. The company is actively involved in developing diagnostics for infectious diseases, including COVID-19 and sexually transmitted infections, with a focus on point-of-care and over-the-counter testing solutions.
Industries
Nr. of Employees
small (1-50)
Aptitude Medical Systems
Santa Barbara, California, United States, North America
Products
Portable molecular diagnostic platform (reader and consumable assays)
A palm-sized diagnostic reader paired with disposable molecular test consumables designed to run rapid PCR-based assays in decentralized settings without user calibration or maintenance.
COVID-19 molecular test for decentralized and at-home use
A PCR-based molecular test intended for over-the-counter and point-of-care use with saliva and nasal swab samples; documented with Instructions for Use, quick reference guides, and provider fact sheets.
Respiratory multiplex test (COVID/Flu) and pipeline multiplex panels
Multiplex molecular assays in development to detect respiratory pathogens (e.g., SARS-CoV-2 and influenza) and additional syndromic panels for broader infectious disease testing.
Multiplex STI panel (development funded via philanthropic partnership)
Development program for a multiplex panel to detect sexually transmitted infections (CT, NG, TV) intended for point-of-care and over-the-counter use; program supported by external grant funding.
Portable molecular diagnostic platform (reader and consumable assays)
A palm-sized diagnostic reader paired with disposable molecular test consumables designed to run rapid PCR-based assays in decentralized settings without user calibration or maintenance.
COVID-19 molecular test for decentralized and at-home use
A PCR-based molecular test intended for over-the-counter and point-of-care use with saliva and nasal swab samples; documented with Instructions for Use, quick reference guides, and provider fact sheets.
Respiratory multiplex test (COVID/Flu) and pipeline multiplex panels
Multiplex molecular assays in development to detect respiratory pathogens (e.g., SARS-CoV-2 and influenza) and additional syndromic panels for broader infectious disease testing.
Multiplex STI panel (development funded via philanthropic partnership)
Development program for a multiplex panel to detect sexually transmitted infections (CT, NG, TV) intended for point-of-care and over-the-counter use; program supported by external grant funding.
Services
Customer and product support
Technical support for product users via FAQ knowledgebase, support email, and phone lines; assistance with order inquiries and troubleshooting.
Sales and distribution for healthcare and enterprise customers
Commercial sales channels for point-of-care and enterprise deployments, including direct sales, partnerships, and ecommerce.
Partnership and funded program collaboration
Collaboration with government agencies and philanthropic funders to develop and validate diagnostics, and to scale regulatory and commercial activities.
Customer and product support
Technical support for product users via FAQ knowledgebase, support email, and phone lines; assistance with order inquiries and troubleshooting.
Sales and distribution for healthcare and enterprise customers
Commercial sales channels for point-of-care and enterprise deployments, including direct sales, partnerships, and ecommerce.
Partnership and funded program collaboration
Collaboration with government agencies and philanthropic funders to develop and validate diagnostics, and to scale regulatory and commercial activities.
Expertise Areas
- Point-of-care and at-home molecular diagnostics
- Rapid PCR assay design and validation
- Multiplex assay development
- Regulatory submissions and compliance for diagnostics (EUA, 510(k), CLIA)
Key Technologies
- PCR-based molecular diagnostics
- Multiplex nucleic acid assays
- Saliva and nasal swab sample processing
- Portable diagnostic reader hardware